$MBIO +34% AH 🚀 🔹 Mustang Bio ripping after-hours as biotech momentum heats up 📈 🔹 Clinical-stage biotech developing cell therapies for hard-to-treat cancer

$MBIO +34% AH 🚀 🔹 Mustang Bio ripping after-hours as biotech momentum heats up 📈 🔹 Clinical-stage biotech developing cell therapies for hard-to-treat cancers 🧬 🔹 Pipeline includes MB-101, an IL13Rα2-targeted CAR-T candidate for astrocytomas & glioblastoma 🔬 🔹 Recent FDA Orphan Drug Designati…